CrushSCI.com
239.0平均天数
238中位天数
92最短天数
433最长天数
4032025发文量

Paper Review Records

全部论文审稿周期

25 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

147 天

PDGF-BB and bFGF repress Kai1 in pericytes through Src–DNMT-associated promoter methylation and lysosomal trafficking

作者
Cheong-Whan Chae; Taehun Yoon; Yoo-Wook Kwon; Hyo-Soo Kim展开收起
作者单位
1. Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; 2. Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea; 3. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea展开收起
PDF源文件 DOI 网页
249 天

B3GNT9-mediated O-glycosylation reprograms fatty acid metabolism in peroxisomes to promote invasion progression of peritumoral glioma cells

作者
Zechuan Peng; Jiasheng Zhong; Shengsong Fu; Yunhe Zhao; Jie Liu; Fei Wu; Zetao Chen; Tianwei Wang; Yiquan Ke; Taoliang Chen展开收起
作者单位
1. Neurosurgery Center, Zhujiang Hospital, Southern Medical University, Guangzhou, China; 2. Department of Neuro-oncological Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China; 3. National Key Clinical Specialty, Zhujiang Hospital, Southern Medical University, Guangzhou, China; 4. Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cerebrovascular Diseases, Ministry of Education, Southern Medical University, Guangzhou, China; 5. Guangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, Southern Medical University, Guangzhou, China; 6. Zhujiang Hospital Institute for Brain Science and Intelligence, Zhujiang Hospital, Southern Medical University, Guangzhou, China; 7. Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, Guangzhou, China展开收起
PDF源文件 DOI 网页
433 天

RHBDL2 promotes cancer stemness and chemoresistance in triple-negative breast cancer through EGFR/PI3K/AKT/mTOR/c-Myc pathway

作者
Dan Wang; Xing Niu; Jingqi Tian; Ruibin Liu; Yuxuan Song; Dingye Zhang; Junze Dai; Shenglong Li; Xudong Zhu展开收起
作者单位
1. Department of Breast and Thyroid Surgery, Dalian Economic and Technological Development Zone Hospital, Dalian, China; 2. Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China; 3. China Medical University, Shenyang, China; 4. Department of Hepatopancreatobiliary Surgery, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital and Institute, Shenyang, China; 5. Liaoning Provincial Key Laboratory of Precision Medicine for Malignant Tumors, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, China; 6. Department of Bone and Soft Tissue Tumor Surgery, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, China; 7. State Key Laboratory of Oncology in South China, Guangzhou, China; 8. Fujian Provincial Key Laboratory of Tumor Biotherapy, Fuzhou, China展开收起
PDF源文件 DOI 网页
179 天

Disassembly of PKA holoenzyme organization marks prostate cancer progression

作者
Tal Benjamin-Zukerman; Ran Katz; Gilat Shimon; Meir Solomon; Mirjam M. Nordling-David; Puspashree Sahoo; Basem Hijazi; Ali Safadi; Ronit Ilouz展开收起
作者单位
1. The Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel; 2. Department of Urology, Ziv Medical Center, affiliated with Azrieli Faculty of Medicine in the Galilee, Safed, Israel; 3. The Leslie & Susan Goldschmied (Gonda) Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat Gan, Israel展开收起
PDF源文件 DOI 网页
313 天

Therapy-induced tumour senescence drives oxaliplatin resistance via ADORA1–dependent palmitic acid metabolic reprogramming in colorectal cancer

作者
Yuqin Long; Xue Li; Yunxi Zhu; Yang Shen; Xiaotian Zhou; Ziqin Wei; Yin Yue; Jie Zhang; Changhong Miao展开收起
作者单位
1. Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China; 2. Shanghai Key Laboratory of Perioperative Stress and Protection, and Shanghai Clinical Research Center for Anesthesiology, Shanghai, China; 3. Department of Anesthesiology, Shanghai Medical College, Fudan University, Shanghai, China展开收起
PDF源文件 DOI 网页
379 天

Stabilization of LTBP2 by SIRT1 promotes EMT and chemosensitivity in cardia gastric adenocarcinoma through TGF-β signaling

作者
Wang Zhenxiang; Tian Tongguan; Chen Ying; Zhang Yan; Qian Meng; Sun Huihui; Xu Yanping; Xu Shuchang展开收起
作者单位
1. Department of Gastroenterology, Tongji Institute of Digestive Diseases, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China; 2. Tongji Hospital, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, China展开收起
PDF源文件 DOI 网页

FAQ

ONCOGENE审稿要多久?

截至2026-11-18,CrushSCI 收录了 ONCOGENE 的 25 篇完整审稿记录。最快一篇从收稿到录用用了 92 天(tRNA-derived small RNAs in tumor microenvironment remodeling: From mechanistic insights to therapeutic perspectives,2026-04-21 收稿,2026-07-22 录用),最慢一篇用了 433 天;平均 239.0 天,中位数 238 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。